Novartis: LEADing in Emerging Markets
With growth as its guiding light, Novartis has big plans for the emerging markets. Pharm Exec sits down with CEO Joe Jimenez to understand what it will take the company to best the competition.
Pharmaceutical Executive Digital Edition - March 2012
Leading in Emerging Markets
How Can We Fix the FDA?
How can we better balance addressing medical needs with ensuring that new drugs are safe and effective? Ron Cohen reports.
The Italian's Job
After his predecessor and countryman left the EMA in disgrace, Guido Rasi jumps in as executive director-with great challenges ahead.
Off the Hook? Pharm Exec's Annual Press Audit
Our annual press audit finds that the big news in 2011 for pharma was ... no news.
The Maestros
Pharm Exec's latest EAB meeting offered a frank exchange on this magazine's digital future.
The (Life) Science of Digital Connections
Making real connections that resonate with audiences in a digital world is a fine art, especially in the heavily regulated world of Big Pharma
Judging a Pill by its Cover
Pharmaceutical trade dres is an effective marketing tool that helps boost product recognition for consumers. It's worth protecting.
When Talk is Not So Cheap
FDA and industry are pushing user fees, while they struggle with curbs on communications.
Betting on Bigger Data
In the rush to collect as much patient data as possible, are we sacrificing quality for quantity? Ben Comer reports.
